<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
84148-010-01
</NDCCode>
<PackageDescription>
30 g in 1 BOTTLE (84148-010-01)
</PackageDescription>
<NDC11Code>
84148-0010-01
</NDC11Code>
<ProductNDC>
84148-010
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
15% Azelaic Acid Acne Cream
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
15% Azelaic Acid Acne Cream
</NonProprietaryName>
<DosageFormName>
CREAM
</DosageFormName>
<RouteName>
CUTANEOUS
</RouteName>
<StartMarketingDate>
20240923
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
UNAPPROVED DRUG OTHER
</MarketingCategoryName>
<ApplicationNumber/>
<LabelerName>
Guangzhou Ariel Biotech Co., Ltd.
</LabelerName>
<SubstanceName>
ASIATICOSIDE; AZELAIC ACID; CAPRYLOYL GLYCINE; CENTELLA ASIATICA TRITERPENOIDS; HYDROXYETHYLPIPERAZINE ETHANE SULFONIC ACID; LAVANDIN OIL; MADECASSOSIDE; O-CYMEN-5-OL; TARAXACUM OFFICINALE LEAF
</SubstanceName>
<StrengthNumber>
.015; 15; .15; .03; .5; .03; .055; .09; .01
</StrengthNumber>
<StrengthUnit>
g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g; g/100g
</StrengthUnit>
<Pharm_Classes>
Decreased Protein Synthesis [PE], Decreased Sebaceous Gland Activity [PE]
</Pharm_Classes>
<DEASchedule/>
<Status>
Active
</Status>
<LastUpdate>
2024-10-10
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20251231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20240930
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>